A citation-based method for searching scientific literature

F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. N Engl J Med 2010
Times Cited: 9840



Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn, Enric Carcereny, Myung-Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D Hellmann, Omid Hamid, Jonathan W Goldman, Jean-Charles Soria, Marisa Dolled-Filhart, Ruth Z Rutledge, Jin Zhang, Jared K Lunceford, Reshma Rangwala, Gregory M Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi. N Engl J Med 2015
Times Cited: 3804




List of shared articles



Times cited


Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead.
Basak Aru, Mojdeh Soltani, Cemil Pehlivanoglu, Ege Gürlü, Mazdak Ganjalikhani-Hakemi, Gülderen Yanikkaya Demirel. Front Oncol 2022
0

Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, Thomas Jung, Stephan Grabbe, Matthias Bros. Cancers (Basel) 2022
0

Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma.
Longqing Li, Yang Wang, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Taojun Gong, Qing Chang, Jingqi Lin, Chuang Liu, Yi Luo,[...]. Front Immunol 2022
0

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.
Daniel R Principe, Rui Xiong, Yangfeng Li, Thao N D Pham, Suneel D Kamath, Oleksii Dubrovskyi, Kiira Ratia, Fei Huang, Jiong Zhao, Zhengnan Shen,[...]. Proc Natl Acad Sci U S A 2022
2

Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer.
Daniel R Principe, Patrick W Underwood, Sandeep Kumar, Kaytlin E Timbers, Regina M Koch, Jose G Trevino, Hidayatullah G Munshi, Ajay Rana. Front Oncol 2022
2

The evolutionary legacy of immune checkpoint inhibitors.
Itishree Kaushik, Sharavan Ramachandran, Carson Zabel, Shreyas Gaikwad, Sanjay K Srivastava. Semin Cancer Biol 2022
2

The immune modifying effects of chemotherapy and advances in chemo-immunotherapy.
Daniel R Principe, Suneel D Kamath, Murray Korc, Hidayatullah G Munshi. Pharmacol Ther 2022
2

Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
Jay Ponto, R Bryan Bell. Oral Maxillofac Surg Clin North Am 2022
0

CD39 - A bright target for cancer immunotherapy.
Shuwei Guo, Fengfeng Han, Wei Zhu. Biomed Pharmacother 2022
0

Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.
Tae Kon Kim, Esten N Vandsemb, Roy S Herbst, Lieping Chen. Nat Rev Drug Discov 2022
0